No abstract

Acoustic sensors that exploit resonating quartz crystals to directly detect the binding of an analyte to a receptor are finding increasing utility in the quantification of clinically-relevant analytes. We have developed a novel acoustic detection technology, which we term Resonant Acoustic Profiling (RAP™). This technology builds on the fundamental basics of the "quartz crystal microbalance" or "QCM" with several key additional features including two-or four-channel automated sample delivery, in-line referencing and microfluidic sensor 'cassettes' that are pre-coated with easy-to-use surface chemistries. Example applications are described for the quantification of myoglobin concentration and its interaction kinetics, and for the ranking of enzyme-cofactor specificities.